-+ 0.00%
-+ 0.00%
-+ 0.00%

Korro Bio to present preclinical KRRO-121 hyperammonemia data at ASGCT meeting

PUBT·04/16/2026 11:34:42
Listen to the news
Korro Bio to present preclinical KRRO-121 hyperammonemia data at ASGCT meeting
  • Korro Bio flagged upcoming scientific conference presentations that highlight preclinical data for KRRO-121, an RNA-editing oligonucleotide being developed for hyperammonemia.
  • Data will be presented in future sessions at ASGCT on May 14 and at Ureagenesis Defects conference on April 24.
  • Management plans to outline findings indicating KRRO-121 produced strong ammonia clearance in multiple preclinical model systems.
  • Separate ASGCT presentation on May 15 will preview preclinical results showing RNA editing restored Alpha-1 Antitrypsin function in models of Alpha-1 Antitrypsin Deficiency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief on April 16, 2026, and is solely responsible for the information contained therein.